{"log_id": 3431560296224199722, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 1.1e-05, "average": 0.998785, "min": 0.979694}, "location": {"width": 853, "top": 111, "height": 47, "left": 245}, "words": "(5)在多西他赛开始滴注的最初几分钟内有可能发生过敏反应。如果发生过敏反应"}, {"probability": {"variance": 3e-06, "average": 0.999105, "min": 0.991461}, "location": {"width": 909, "top": 146, "height": 47, "left": 189}, "words": "的症状轻微如脸红或局部皮肤反应则不需中止治疗。如果发生严重过敏反应,如血压下降"}, {"probability": {"variance": 0.004886, "average": 0.978825, "min": 0.6069}, "location": {"width": 909, "top": 181, "height": 47, "left": 191}, "words": "超过20mmHg,支气管痉挛或全身皮疹/红斑,则需立即停止滴注并进行对症治疗,对已发"}, {"probability": {"variance": 0, "average": 0.999685, "min": 0.998486}, "location": {"width": 469, "top": 223, "height": 40, "left": 191}, "words": "生严重不良反应的病人不能再次应用多西他赛"}, {"probability": {"variance": 2e-06, "average": 0.999198, "min": 0.992743}, "location": {"width": 850, "top": 251, "height": 45, "left": 247}, "words": "(6)多西他赛治疗期间可能发生外周神经毒性。如果反应严重,则建议在下一个疗"}, {"probability": {"variance": 5.1e-05, "average": 0.996458, "min": 0.980499}, "location": {"width": 142, "top": 302, "height": 29, "left": 191}, "words": "程中减低剂量"}, {"probability": {"variance": 0.000122, "average": 0.996496, "min": 0.932235}, "location": {"width": 853, "top": 322, "height": 46, "left": 247}, "words": "(7)如已观察到的皮肤反应有肢端(手心或足底)局部性红斑伴水肿、脱皮等。此"}, {"probability": {"variance": 1e-06, "average": 0.999524, "min": 0.996882}, "location": {"width": 327, "top": 369, "height": 33, "left": 192}, "words": "类毒性可能导致中断或停止治疗"}, {"probability": {"variance": 3e-06, "average": 0.998977, "min": 0.993806}, "location": {"width": 842, "top": 392, "height": 46, "left": 262}, "words": "8)肝功能有损害的病人:如果血清转氨酶(ALT和、或AST)超过正常值上限1.5"}, {"probability": {"variance": 1e-06, "average": 0.999537, "min": 0.995667}, "location": {"width": 909, "top": 426, "height": 48, "left": 192}, "words": "倍,同时伴有碱性磷酸酶超过正常值上限2.5倍,存在发生严重不良反应的高度危险,如"}, {"probability": {"variance": 1e-06, "average": 0.999363, "min": 0.994135}, "location": {"width": 908, "top": 462, "height": 46, "left": 193}, "words": "毒性死亡,包括致死的脓毒症,胃肠道出血,以及发热性中性粒细胞减少症,感染,血小"}, {"probability": {"variance": 1e-06, "average": 0.999352, "min": 0.995367}, "location": {"width": 910, "top": 496, "height": 46, "left": 193}, "words": "板减少症,口炎和乏力。因此,这些病人不应使用,并且在基线和每个化疗周期前要检测"}, {"probability": {"variance": 0, "average": 0.999551, "min": 0.999173}, "location": {"width": 71, "top": 549, "height": 25, "left": 193}, "words": "肝功能"}, {"probability": {"variance": 1.7e-05, "average": 0.998816, "min": 0.976746}, "location": {"width": 902, "top": 564, "height": 47, "left": 201}, "words": "【孕妇及哺乳期妇女用药】目前尚无足够的和严格控制的孕妇临床研究资料。如果患者"}, {"probability": {"variance": 2.8e-05, "average": 0.997737, "min": 0.968958}, "location": {"width": 897, "top": 599, "height": 46, "left": 194}, "words": "在孕期使用本品,或在使用本品期间怀孕,应被告之对胎儿的潜在危害和流产的潜在危险"}, {"probability": {"variance": 1e-06, "average": 0.999198, "min": 0.994309}, "location": {"width": 910, "top": 634, "height": 46, "left": 195}, "words": "有生育可能的妇女在使用本品治疗期间应避免怀孕。尚不清楚多西他赛是否从人乳中排"}, {"probability": {"variance": 1e-06, "average": 0.999395, "min": 0.995616}, "location": {"width": 910, "top": 668, "height": 46, "left": 195}, "words": "泄。鉴于许多药物都可从人乳中排泄,且多西他赛可能引起哺乳婴儿的严重不良反应,母"}, {"probability": {"variance": 1.2e-05, "average": 0.998432, "min": 0.987314}, "location": {"width": 282, "top": 714, "height": 35, "left": 196}, "words": "亲在使用本品前应停止哺乳"}, {"probability": {"variance": 6e-06, "average": 0.99862, "min": 0.987961}, "location": {"width": 636, "top": 745, "height": 38, "left": 203}, "words": "【儿童用药】多西他赛应用于儿童的有效性及安全性尚未确定"}, {"probability": {"variance": 4e-06, "average": 0.998809, "min": 0.993196}, "location": {"width": 241, "top": 787, "height": 28, "left": 204}, "words": "【老年用药】尚不明确"}, {"probability": {"variance": 1.5e-05, "average": 0.99814, "min": 0.977609}, "location": {"width": 902, "top": 809, "height": 43, "left": 204}, "words": "【药物相互作用】体外研究表明CYP3A4抑制剂可能干扰本品的代谢,因此当与此类药物"}, {"probability": {"variance": 1.2e-05, "average": 0.99769, "min": 0.986118}, "location": {"width": 573, "top": 847, "height": 40, "left": 207}, "words": "(如酮康唑、红霉素、环孢素等)同时应用时应格外小心"}, {"probability": {"variance": 5e-05, "average": 0.997568, "min": 0.956472}, "location": {"width": 880, "top": 878, "height": 43, "left": 203}, "words": "【药物过量】一旦发生过量,应将病人移至特殊监护病房内并严密监测重要器官功能"}, {"probability": {"variance": 1.2e-05, "average": 0.998544, "min": 0.978307}, "location": {"width": 909, "top": 913, "height": 44, "left": 198}, "words": "多西他赛过量,尚无解救药可用。可预料到的过量主要并发症包括中性粒细胞减少,皮肤"}, {"probability": {"variance": 0, "average": 0.999756, "min": 0.99943}, "location": {"width": 165, "top": 959, "height": 32, "left": 198}, "words": "反应和感觉异常"}, {"probability": {"variance": 1e-06, "average": 0.999341, "min": 0.997322}, "location": {"width": 127, "top": 996, "height": 26, "left": 203}, "words": "【药理毒理】"}, {"probability": {"variance": 2.6e-05, "average": 0.997443, "min": 0.977287}, "location": {"width": 397, "top": 1025, "height": 35, "left": 197}, "words": "药理学分类:A26细胞(生长)抑制剂"}, {"probability": {"variance": 0.001955, "average": 0.970041, "min": 0.89396}, "location": {"width": 168, "top": 1029, "height": 36, "left": 926}, "words": "深圳万业"}, {"probability": {"variance": 0, "average": 0.999603, "min": 0.999265}, "location": {"width": 95, "top": 1065, "height": 26, "left": 199}, "words": "药理作用"}, {"probability": {"variance": 0.000298, "average": 0.995897, "min": 0.893531}, "location": {"width": 864, "top": 1086, "height": 42, "left": 245}, "words": "多西他赛为紫杉醇类抗肿瘤药,通过干扰细胞有丝分裂和分裂间期细胞功能所必需的"}, {"probability": {"variance": 1e-06, "average": 0.999206, "min": 0.995201}, "location": {"width": 908, "top": 1122, "height": 41, "left": 198}, "words": "微管网络而产生抗肿瘤作用。多西他赛可与游离的微管蛋白结合,促进微管蛋白装配成稳"}, {"probability": {"variance": 5e-06, "average": 0.998971, "min": 0.988599}, "location": {"width": 886, "top": 1157, "height": 41, "left": 198}, "words": "定的微管,同时抑制其解聚,导致丧失正常功能的微管束产生,并使微管处于稳定状态"}, {"probability": {"variance": 1.2e-05, "average": 0.998634, "min": 0.979649}, "location": {"width": 908, "top": 1193, "height": 40, "left": 199}, "words": "从而抑制细胞的有丝分裂。多西他赛与微管的结合不改变原丝的数目,这一点与目前临床"}, {"probability": {"variance": 1e-06, "average": 0.999184, "min": 0.997375}, "location": {"width": 353, "top": 1233, "height": 32, "left": 200}, "words": "应用的大多数纺锤体毒性药物不同"}, {"probability": {"variance": 6e-06, "average": 0.998322, "min": 0.994087}, "location": {"width": 93, "top": 1274, "height": 26, "left": 200}, "words": "毒理研究"}, {"probability": {"variance": 7.1e-05, "average": 0.995589, "min": 0.978795}, "location": {"width": 101, "top": 1308, "height": 27, "left": 200}, "words": "遗传毒性:"}, {"probability": {"variance": 0.002367, "average": 0.985514, "min": 0.780225}, "location": {"width": 851, "top": 1333, "height": 37, "left": 246}, "words": "在CHO-K1细胞染色体畸变试验和小鼠骨髓微核试验中,多西他赛表现出致断裂作用"}, {"probability": {"variance": 0.000135, "average": 0.992771, "min": 0.960804}, "location": {"width": 621, "top": 1369, "height": 36, "left": 198}, "words": "但在Ames试验和CHO/ HGPRT基因突变试验中未见致突变作用"}, {"probability": {"variance": 1e-06, "average": 0.999464, "min": 0.998086}, "location": {"width": 94, "top": 1411, "height": 25, "left": 199}, "words": "生殖毒性"}, {"probability": {"variance": 4.3e-05, "average": 0.997365, "min": 0.963646}, "location": {"width": 842, "top": 1438, "height": 33, "left": 247}, "words": "在大鼠静脉注射多西他赛0.3mg/kg(按体表面积折算,约为临床推荐剂量的1/50)"}, {"probability": {"variance": 5.7e-05, "average": 0.997427, "min": 0.955924}, "location": {"width": 907, "top": 1470, "height": 40, "left": 198}, "words": "未见对生育力的损伤,但可引起睾丸重量减轻。该结果与大鼠和犬10个给药周期(每21"}, {"probability": {"variance": 4e-06, "average": 0.998829, "min": 0.991045}, "location": {"width": 908, "top": 1506, "height": 38, "left": 199}, "words": "天给药1次,连续6个月)的重复给药试验结果有相关性:大鼠和犬静脉注射剂量分别为"}, {"probability": {"variance": 0.000377, "average": 0.991809, "min": 0.889792}, "location": {"width": 890, "top": 1539, "height": 42, "left": 201}, "words": "5g/kg和0.375mg/kg时(按体表面积折算,分别约相当于临床推荐剂量的1/3和1/5)"}], "language": 3}